Publication Name	世界华人消化杂志
手稿编号	38183
手稿来源省、自治区或特别行政区	黑龙江省

Received	2021-02-05 11:24
Peer-Review Started	2021-02-05 12:27
To Make the First Decision
Return for Revision	2021-03-08 18:18
修回稿	2021-04-06 07:40
Second Decision	2021-05-11 07:02
期刊总编辑接受
公司总编辑接受	2021-05-11 19:20
预出版	2021-05-11 19:20
缴纳版面费
Edit the Manuscript by Language Editor
排版	2021-06-28 09:09
在线出版	2021-06-28 12:18

ISSN	1009-3079 (print) and 2219-2859 (online)
开放获取	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
版权	©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
网址	http://www.wjgnet.com

专业类型	消化肿瘤学
手稿栏目类型	述评
文章标题	靶向SRC治疗胰腺癌的研究新进展
手稿来源	约稿
所有作者列表	李子一, 孙学英
基金项目及其编号	基金项目名称 基金编号 国家重点研发计划资助项目 2017YFC1308602
通讯作者	孙学英, 博士, 教授, 150001, 哈尔滨市邮政街23号, 哈尔滨医科大学第一附属医院肝脾外科中心. kevsun88@hotmail.com
关键词	SRC; SRC抑制剂; 胰腺癌; 靶向治疗; 化疗; 临床试验
核心内容提要	SRC在70%胰腺癌中高表达. 小分子SRC抑制剂展示有效的抗胰腺癌活性, 一些SRC抑制剂进入胰腺癌治疗的临床试验. SRC是治疗胰腺癌的潜在分子靶点, 靶向SRC将成为治疗胰腺癌新希望.
出版日期	2021-06-28 12:18
引文著录	李子一, 孙学英. 靶向SRC治疗胰腺癌的研究新进展. 世界华人消化杂志 2021; 29(12): 621-627
URL	https://www.wjgnet.com/1009-3079/full/v29/i12/621.htm
DOI	https://dx.doi.org/10.11569/wcjd.v29.i12.621

Full Article (PDF)	WCJD-29-621.pdf
审稿意见	WCJD-38183-Peer-review(s).pdf
科学编辑工作清单	WCJD-38183-Scientific editor work list.pdf